HOSPICES CIVILS DE LYON

🇫🇷France

Country: 🇫🇷France

Ownership: -

Established: 1796-01-01

Employees: 10K

Market Cap: -

Website: http://www.chu-lyon.fr

Clinical Trials

Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study.

Not Applicable

Terminated

Conditions: Critical Illness

Interventions: Drug: Human insulin - Insulin administration to control blood glucose level.

First Posted Date: 2014-09-18

Last Posted Date: 2018-01-04

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 2069

Registration Number: NCT02244073

Locations: 🇫🇷
CHU de Saint Etienne - Hôpital Nord, St Priest en Jarez, France
🇫🇷
Centre Hospitalier de Salon de Provence, Salon de Provence, France
🇫🇷
CHU de Clermont Ferrand - Gabriel Montpied, Clermont Ferrand, France

and more 9 locations

Confocal Laser Endomicroscopy for Brain Tumors

Phase 1

Terminated

Conditions: Low Grade Glioma (LGG), High Grade Glioma (HGG)

Interventions: Procedure: confocal endomicroscopy with the CELLVIZIO® system (Mauna Kea technology)

First Posted Date: 2014-09-16

Last Posted Date: 2015-11-26

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 10

Registration Number: NCT02240758

Locations: 🇫🇷
Hospices Civils de Lyon, Lyon, France

Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria.

Phase 4

Completed

Conditions: Chronic Kidney Disease
Renal Transplantation
Nephrotic Syndrome

Interventions: Drug: Cholecalciferol vial (100 000 UI)

First Posted Date: 2014-09-12

Last Posted Date: 2018-07-18

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 43

Registration Number: NCT02238418

Locations: 🇫🇷
Centre de Référence des Maladies Rénales Rares - Hospices Civils de Lyon - Service de Néphrologie et Rhumatologie Pédiatriques - Hôpital Femme Mère Enfant, Bron, France

Bile Acids and Incretins in Pancreas Kidney Transplant Patients

Not Applicable

Completed

Conditions: Pancreas-kidney Transplantation
Kidney Transplantation

Interventions: Procedure: pancreas kidney transplantation
Procedure: kidney transplantation

First Posted Date: 2014-09-09

Last Posted Date: 2018-11-29

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 50

Registration Number: NCT02234349

Locations: 🇫🇷
Hôpital Edourad Herriot - Pavillon P, LYON cedex 03, France

Follow up of Neurologic Development of Children Who Presented at the First Trimester of Pregnancy an Isolated Nuchal Anomaly With Normal Karyotype

Not Applicable

Completed

Conditions: Neurological Development After Exposition to an Antenatal Nuchal Translucency

Interventions: Other: group exposed
Other: Control

First Posted Date: 2014-08-22

Last Posted Date: 2014-08-22

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 500

Registration Number: NCT02223936

Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot Study

Phase 2

Completed

Conditions: Toxic Shock Syndrome

Interventions: Drug: Intravenous human immunoglobulin
Drug: Albumin

First Posted Date: 2014-08-18

Last Posted Date: 2021-06-08

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 30

Registration Number: NCT02219165

Locations: 🇫🇷
Hôpital Femme Mère Enfant, Bron, France

PROACTIVE Study Evaluation of the Impact of a Multidimensional Geriatric Intervention Program

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Other: No intervention

First Posted Date: 2014-08-13

Last Posted Date: 2019-03-21

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 12

Registration Number: NCT02216162

Locations: 🇫🇷
Claire Falandry, Lyon, France

Potentiation of the Effects of Prismatic Adaptation by Transcranial Direct Current Stimulation (tDCS) : Evaluation of Functional Interest in Negligence Rehabilitation

Not Applicable

Completed

Conditions: Neurologic Neglect Syndrome

Interventions: Device: transcranial direct current stimulation (tDCS)

First Posted Date: 2014-08-11

Last Posted Date: 2018-08-14

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 24

Registration Number: NCT02213640

Locations: 🇫🇷
Hôpital henri Gabriel (Hospices Civils de Lyon), Saint-Genis Laval, France

Nilotinib ± Peg-IFN for First Line Chronic Phase CML Patients

Phase 3

Conditions: Chronic Myeloid Leukemia

Interventions: Drug: Nilotinib (Tasigna ®), capsules of 150 mg
Drug: Nilotinib (Tasigna ®) and Pegylated interferon alfa 2a (Pegasys®)

First Posted Date: 2014-07-28

Last Posted Date: 2014-08-07

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 200

Registration Number: NCT02201459

Locations: 🇫🇷
Franck NICOLINI, Lyon, France

Study of the Relationship Between Clinical and Paraclinical Markers During Situations of Cachexia and Pre-cachexia in Patients Over 70 Years With Colorectal Surgery

Not Applicable

Completed

Conditions: Colorectal Tumor

Interventions: Procedure: Biopsy of adipose and muscular tissue
Other: Blood sampling
Other: Calorimetry
Other: Impedance measure
Other: Evaluation of nutritional status
Other: Evaluation of physical performance
Other: Evaluation of muscular strength
Other: Evaluation of emotional status
Other: Evaluation of functional status

First Posted Date: 2014-07-25

Last Posted Date: 2018-11-23

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 59

Registration Number: NCT02199912

Locations: 🇫🇷
Groupement Hospitalier Sud - Service de Médecine Gériatrique, Pierre Benite, France

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy